secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantheus Holdings, Inc. (LNTH)
CIK:        0001521036
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001628280-25-022871
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantheus Q1 adj EPS $1.53 (-9.5% YoY); cuts FY25 adj EPS guidance to $6.60-$6.70 from $7.00-$7.20
--------------------------------------------------------------------------------

- Q1 revenue $372.8M (+0.8% YoY); GAAP EPS $1.02 vs $1.87; adj EPS $1.53 vs $1.69.
- PYLARIFY sales $257.7M (-0.5%); DEFINITY $79.2M (+3.5%).
- FY2025 revenue guidance narrowed to $1.550B-$1.585B; adj EPS guidance lowered to $6.60-$6.70 from $7.00-$7.20.
- Closed Evergreen Theragnostics; agreed to acquire Life Molecular Imaging (Q2); announced SPECT divestiture to SHINE (by year-end).
- MK-6240 met endpoints in pivotal studies; NDA planned Q3 2025. PNT2002 will not proceed to NDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1521036/000162828025022871/0001628280-25-022871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1521036/000162828025022871/lnth-20250507.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-022871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer